Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Innoviva Inc (NASDAQ:INVA)

10.17
Delayed Data
As of Jun 28
 +0.26 / +2.62%
Today’s Change
6.36
Today|||52-Week Range
19.33
-3.51%
Year-to-Date

Today’s Trading

Previous close9.91
Today’s open10.07
Day’s range9.92 - 10.34
Volume1,048,741
Average volume (3 months)676,997
Market cap$1.1B
Dividend yield9.84%
Data as of 06/28/2016

Growth & Valuation

Earnings growth (last year)+89.33%
Earnings growth (this year)+438.75%
Earnings growth (next 5 years)+3.00%
Revenue growth (last year)+247.57%
P/E ratioNM
Price/Sales17.94
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ACORAcorda Therapeutics ...+0.83+3.39%
ALDRAlder Biopharmaceuti...+1.18+5.15%
EBSEmergent BioSolution...+1.08+3.96%
PRTAProthena Corporation...+2.38+7.04%
Data as of 06/28/2016

Financials

Next reporting dateJuly 27, 2016
EPS forecast (this quarter)$0.11
Annual revenue (last year)$67.8M
Annual profit (last year)-$18.8M
Net profit margin-27.68%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Michael W. Aguiar
Chief Financial Officer &
Senior Vice President
Eric d'Esparbes
Corporate headquarters
South San Francisco, California

Forecasts

Partner Offers

Search for Jobs